$29.76
1.154.02%
Last update: Nov 11, 12:53 PM
Alto Neuroscience Inc
ANRONYSE
Alto Neuroscience rose 113.5% from $13.40 to $28.61, ahead of the S&P 500's +9.8%. Its worst day was Nov 13 (−20.1%), and its low came Nov 13 at $11.35.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.52 beat the $-0.65 estimate on $0.00 revenue.
+6.0% · S&P 500 +0.1%
Alto Neuroscience shares rose 12.6%, while the S&P 500 fell 0.2%.
Story events cover the past 12 months · Times ET
+12.6% · S&P 500 −0.2%
Alto Neuroscience shares rose 14.0%, while the S&P 500 rose 0.2%.
+14.0% · S&P 500 +0.2%
EPS of $-0.45 beat the $-0.53 estimate on $0.00 revenue.
+9.1% · S&P 500 +1.0%
Alto Neuroscience shares rose 12.5%, while the S&P 500 rose 2.9%.
+12.5% · S&P 500 +2.9%
6,000,000 SharesCommon Stock Offered by the Selling StockholdersThis prospectus relates to the proposed resale from time to time of up to 6,000,000 shares, or the Shares, of our common stock, par value $0.0001 per share,
+13.0% · S&P 500 +1.0%
EPS of $-0.80 missed the $-0.52 estimate on $0.00 revenue.
−7.2% · S&P 500 +0.6%
Alto Neuroscience shares rose 16.0%, while the S&P 500 fell 0.3%.
+16.0%, the year's best day · S&P 500 −0.3%
EPS of $-0.65 beat the $-0.76 estimate on $0.00 revenue.
+10.7% · S&P 500 +0.7%
Alto Neuroscience closed at its highest level of the year, 173.4% above where the year started.
+4.1% · S&P 500 +0.4%
Where it ended: a close of $28.61 on Nov 10, 2026.
Nothing in the past 12 months.
All ANRO dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ANRO and SPY from Benzinga historical bars. Not investment advice.
